Medical Microinstruments Appoints Healthcare Industry Veteran Mark Toland as Chief Executive Officer
USA - English
News provided by
Share this article
Share this article
CALCI, Italy, Jan. 12, 2021 /PRNewswire/ Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today the hiring of Mark Toland as Chief Executive Officer. He brings more than 25 years of experience in the medical device industry and most recently served as President and CEO of Corindus, a vascular robotics company that Siemens Healthineers acquired for $1.1 billion in 2019. Following the CE mark of MMI s Symani Surgical System® in 2019 and successfully completing the first human use cases in 2020, Toland will drive the company s strategic direction from the developmental stage to broad commercialization.
Factors such as Increasing patient volume and subsequent growth in the demand for health insurance, the growing importance of denials management, declining reimbursement rates, increase in the volume of unstructured data in the healthcare industry, and the rising need to curtail escalating healthcare costs are the major factors driving the growth of this market.
This study analyzes the Patient access solutions market based on their product & service type, delivery mode type, and end-user.
Services segment to have the largest share in 2019
Based on product and service, the market is segmented into services and software. The services segment accounted for the largest share of the global market in 2019. The introduction of complex software and the need for system integration are expected to boost the services market in the coming years.
/PRNewswire/ Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today.
/PRNewswire/ ValueHealth, LLC announced it has broken ground on the construction of its new total joint hyperspecialty surgery center and Stay Suites Muve.
Share this article
Share this article
CHICAGO, Jan. 12, 2021 /PRNewswire/ Sterling Bay today announced that Dr. Suzet McKinney has joined as Principal and Director for Sterling Bay s Life Sciences Division. In her role Dr. McKinney will oversee Sterling Bay s relationships with the scientific, academic, corporate, tech and governmental sectors involved in the life science ecosystem, as well as manage the experience and facilitate the growth of life science tenants in Sterling Bay developments. Dr. McKinney is a nationally recognized public health expert who brings decades of experience and qualified medical expertise to the company.
Suzet McKinney I m thrilled to join Sterling Bay as we seize this opportunity to pioneer the future of Life Sciences in Chicago and around the world, said Dr. Suzet McKinney. I look forward to bringing together groundbreaking healthcare and life sciences organizations that improve social and health outcomes throughout the city, creating jobs and